HDFC Pharma and Healthcare Fund Regular Growth

HDFC Pharma and Healthcare Fund Regular Growth

Equity

HDFC Mutual Fund

Sector - Healthcare

Get the latest NAV of HDFC Pharma and Healthcare Fund Regular Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹16.83

▲1.2%1D

NAV as on 30 Jun 2025

35.19%/per year

Since Inception

Absolute Gain%

▲▼

HDFC Pharma and Healthcare Fund Regular Growth Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (30-Jun-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, but underperformed over 3Y, 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
3.77%
3.58%
2.52%
3 Months
5.72%
10.67%
5.5%
6 Months
-1.12%
5.55%
-2.24%
1 Year
28.33%
4.69%
18.17%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
HDFC Pharma and Healthcare Fund Regular Growth
-
1,705Cr
2.02%
28.33%
-
35.19%
SBI Healthcare Opportunities Fund Regular
1/8
3,689Cr
1.94%
20.64%
28.79%
15.56%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.9%
22.29%
29.93%
21.74%
Tata India Pharma & Healthcare Fund Regular
3/8
1,232Cr
2.12%
15.17%
25.16%
12.33%
See all

HDFC Pharma and Healthcare Fund Regular Growth Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

HDFC Pharma and Healthcare Fund Regular Growth Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 98%

Debt & Cash 0.8%

Small cap
35.9%
Large cap
34%
Mid cap
26.6%
Mid Cap allocation has gone up from 26.5% to 26.6%
Mid Cap allocation has gone up from 26.5% to 26.6%
Large Cap allocation has gone down from 36.4% to 34%
Large Cap allocation has gone down from 36.4% to 34%
Small Cap allocation has gone up from 32.8% to 35.9%
Small Cap allocation has gone up from 32.8% to 35.9%
Cash allocation has gone down from 1.6% to 0.8%
Cash allocation has gone down from 1.6% to 0.8%

HDFC Pharma and Healthcare Fund Regular Growth Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 98%

Debt & Cash 0.8%

Health
98%
Basic Materials
2%

Top 3 Sectors in May were Health, Corporate & Basic Materials

May'25

Health

98%

Corporate

54%

Basic Materials

2%

Apr'25

Health

98%

Corporate

38%

Basic Materials

2%

HDFC Pharma and Healthcare Fund Regular Growth Holdings Details

as on (31-May-25)

Equity

Top Stocks bought last month
Divi's Laboratories Ltd's allocation increased from 9.58% to 10.24%
Divi's Laboratories Ltd's allocation increased from 9.58% to 10.24%
Glenmark Pharmaceuticals Ltd's allocation increased from 3.5% to 4.12%
Glenmark Pharmaceuticals Ltd's allocation increased from 3.5% to 4.12%
Gland Pharma Ltd's allocation increased from 2.18% to 2.75%
Gland Pharma Ltd's allocation increased from 2.18% to 2.75%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.26 % to 12.25 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 12.26 % to 12.25 %
Cipla Ltd's allocation decreased from 7.58 % to 7 %
Cipla Ltd's allocation decreased from 7.58 % to 7 %
Lupin Ltd's allocation decreased from 5.59 % to 5.59 %
Lupin Ltd's allocation decreased from 5.59 % to 5.59 %

HDFC Pharma and Healthcare Fund Regular Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio2.02%
Benchmark
BSE Healthcare TR INR
AUM₹1705 Cr
Inception Date4 October, 2023
Min Lumpsum/SIP₹100/₹100
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
28.39%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About HDFC Pharma and Healthcare Fund Regular Growth

HDFC Pharma and Healthcare Fund Regular Growth is an equity fund. This fund was started on 4 October, 2023. The fund is managed by . The fund could potentially beat inflation in the long-run.

Key Parameters

  1. HDFC Pharma and Healthcare Fund Regular Growth has ₹1705 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
  2. The fund has an expense ratio 2.

Returns

HDFC Pharma and Healthcare Fund Regular Growth has given a CAGR return of 35.19% since inception. Over the last 1 year the fund has given a CAGR return of 28.33%.

Holdings

HDFC Pharma and Healthcare Fund Regular Growth has allocated its funds majorly in Health, Corporate, Cash Equivalent, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Cipla Ltd, Lupin Ltd, Max Healthcare Institute Ltd Ordinary Shares

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of HDFC Pharma and Healthcare Fund Regular Growth

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. HDFC Pharma and Healthcare Fund Regular Growth has no lock in period.

Learn more about HDFC Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 1.7K Cr
₹ 1.7K Cr
₹ 1.6K Cr
  • AUM of the fund stands at 1.7K Cr as of May'25
  • AUM increased by 38.5 Cr between May'25 and Apr'25

Frequently Asked Questions for HDFC Pharma and Healthcare Fund Regular Growth

How do I invest in HDFC Pharma and Healthcare Fund Regular Growth?

INDmoney makes it simple to invest in the HDFC Pharma and Healthcare Fund Regular Growth. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘HDFC Pharma and Healthcare Fund Regular Growth’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of HDFC Pharma and Healthcare Fund Regular Growth?

The NAV of the fund today is ₹16.83. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

HDFC Pharma and Healthcare Fund Regular Growth fund has generated a return of 28.33% in 1 year

Who is the fund manager of HDFC Pharma and Healthcare Fund Regular Growth?

The fund managers are .

What is the exit load of the fund?

The exit load is 1% if redeemed in 0-30 Days. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 2.02%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹1705 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of HDFC Pharma and Healthcare Fund Regular Growth?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(12.25%), Divi's Laboratories Ltd(10.24%), Cipla Ltd(7%)